168 related articles for article (PubMed ID: 34445576)
21. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
[TBL] [Abstract][Full Text] [Related]
22. Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.
Amirkhosravi A; Amaya M; Desai H; Francis JL
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):505-12. PubMed ID: 12192302
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
Song H; Rao Y; Zhang G; Kong X
Oncol Res; 2018 Apr; 26(3):457-466. PubMed ID: 28877780
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
25. CD40 activation as potential tool in malignant neoplasms.
Ottaiano A; Pisano C; De Chiara A; Ascierto PA; Botti G; Barletta E; Apice G; Gridelli C; Iaffaioli VR
Tumori; 2002; 88(5):361-6. PubMed ID: 12487551
[TBL] [Abstract][Full Text] [Related]
26. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
Lin L; Cai J
J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
[TBL] [Abstract][Full Text] [Related]
27. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
Nakayama Y; Brinkman CC; Bromberg JS
Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
29. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
30. CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells.
Hermann A; Schrör K; Weber AA
Eur J Cell Biol; 2002 Apr; 81(4):213-21. PubMed ID: 12018389
[TBL] [Abstract][Full Text] [Related]
31. Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.
Nova-Lamperti E; Chana P; Mobillo P; Runglall M; Kamra Y; McGregor R; Lord GM; Lechler RI; Lombardi G; Hernandez-Fuentes MP;
Transplantation; 2017 Mar; 101(3):541-547. PubMed ID: 27472092
[TBL] [Abstract][Full Text] [Related]
32. How CD40L reverse signaling regulates axon and dendrite growth.
Carriba P; Davies AM
Cell Mol Life Sci; 2021 Feb; 78(3):1065-1083. PubMed ID: 32506167
[TBL] [Abstract][Full Text] [Related]
33. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.
Cao Q; Chen M; Li Z; Huang W; Jin Y; Ye X; Tong M
Clin Lab; 2016; 62(1-2):179-86. PubMed ID: 27012048
[TBL] [Abstract][Full Text] [Related]
34. CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors.
Yamada M; Shiroko T; Kawaguchi Y; Sugiyama Y; Egilmez NK; Chen FA; Bankert RB
Int J Cancer; 2001 May; 92(4):589-99. PubMed ID: 11304696
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
Liu Y; Shang D
Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
[TBL] [Abstract][Full Text] [Related]
37. CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway.
Mukundan L; Milhorn DM; Matta B; Suttles J
Cell Signal; 2004 Mar; 16(3):375-84. PubMed ID: 14687667
[TBL] [Abstract][Full Text] [Related]
38. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
Pearson LL; Castle BE; Kehry MR
Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
[TBL] [Abstract][Full Text] [Related]
39. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
[TBL] [Abstract][Full Text] [Related]
40. CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation.
Elmetwali T; Salman A; Wei W; Hussain SA; Young LS; Palmer DH
Sci Rep; 2020 Jan; 10(1):342. PubMed ID: 31941968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
